Diagnostic, screening and treatment delays have always had a significant impact on Canadians living with Parkinson’s and the impacts of … Read More
Research, clinical and other emerging trends in Parkinson’s meeting
On March 26 and 27, 2020, we are hosting a virtual meeting with leading Canadian researchers, clinicians and patients to … Read More
Julie Wysocki speaks at University of Manitoba Café Scientifique
Julie Wysocki, Director Research Program and Partnerships who leads Parkinson Canada’s National Research Program will be moderating UM’s Café Scientifique … Read More
New research shows gut fungi are not associated with Parkinson’s
Since 2014, researchers such as Dr. Silke Appel-Cresswell have been studying the gut as a key area in potentially unravelling … Read More
COVID-19 and Parkinson’s
As the vaccine is rolling out in phases, several provinces have updated eligibility criteria for vaccine prioritization. While Parkinson’s may … Read More
CEO Dr. Karen Lee talks Parkinson Canada’s plans for 2021 on podcast
More than ever, we are here to listen to and support the Parkinson Community, no matter what. This is the … Read More
Living Well with Parkinson’s, Together: No Matter What
Thanks to the support of donors, volunteers and everyone who is part of the Parkinson Community, Parkinson Canada has been … Read More
BlueRock Therapeutics in Collaboration with Memorial Sloan Kettering Cancer Center Receives IND Clearance for DA01 in Parkinson’s Disease
BlueRock Therapeutics shared a news release on January 7, 2020 announcing the funding of a two-year trial using adult donor … Read More
Newly established Parkinson Advisory Council (PAC) prioritizes raising the voice of people affected by Parkinson’s
Raising the voice of people affected by Parkinson’s has always been an important priority of Parkinson Canada and was one … Read More
Gina’s Story: Participating in the Canadian Open Parkinson Network
It was late 2013 and Gina Lupino, 36 at the time, slept for 3 weeks straight, recovering from pneumonia. Gina … Read More







